# Follow Up of Patients Chronic Hepatitis B (CHB) Treated With Sebivo Using the 13C Methacetin Breath Test

> **NCT01204827** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Hadassah Medical Organization**

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DEVICE:** 13C Methacetin Breath Test (BreathID)

## Key facts

- **NCT ID:** NCT01204827
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01204827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01204827, "Follow Up of Patients Chronic Hepatitis B (CHB) Treated With Sebivo Using the 13C Methacetin Breath Test". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01204827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*